## MCHP: Microchip Technology Incorporat - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_10 at 9.4% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops. Caution: momentum weakening (-5.5% MRS).

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($64.31)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. State Street Corp Acquires 2,489,258 Shares of Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251210T120814 | Somewhat-Bullish | Relevance: 99%
- State Street Corp increased its stake in Microchip Technology Incorporated (MCHP) by 8.5%, acquiring an additional 2,489,258 shares to hold a total of 31,888,814 shares, valued at approximately $2.244 billion. Microchip Technology posted Q2 earnings that beat estimates and anticipates Q3 2026 EPS of $0.34–$0.40, while maintaining a "Moderate Buy" consensus rating from analysts. The semiconductor company also declared a quarterly dividend of $0.455 per share.

**2. Federated Hermes Inc. Increases Stock Position in Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251210T100844 | Somewhat-Bullish | Relevance: 99%
- Federated Hermes Inc. significantly increased its stake in Microchip Technology Incorporated (MCHP) by 1,072.5% in the second quarter, now owning 431,775 shares valued at $30.38 million. This move is part of broader institutional investor activity, with hedge funds and other investors owning 91.51% of the company's stock. Analysts generally rate MCHP as a "Moderate Buy," while the company recently reported strong quarterly earnings and declared a quarterly dividend of $0.455 per share.

**3. Daiwa Securities Group Inc. Lowers Stake in Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251211T093429 | Neutral | Relevance: 98%
-  Daiwa Securities Group Inc. reduced its stake in Microchip Technology Incorporated ($MCHP) by 18.5% in Q2, bringing its total holdings to 131,942 shares valued at $9.285 million. Other institutional investors showed mixed activity, while CFO James Eric Bjornholt also sold a portion of his shares. Despite this, Microchip Technology beat Q2 earnings estimates, provided optimistic Q3 guidance, and analyst consensus remains a "Moderate Buy" with an average target price of $74.95.

**4. Microchip Technology (MCHP) Is Up 6.7% After Raising Q3 FY26 Outlook And Launching New AI‑Focused Chips**
- Source: Simply Wall Street | 20251211T020836 | Bullish | Relevance: 98%
-  Microchip Technology (MCHP) announced a raised Q3 FY26 guidance, now expecting roughly 1% sequential net sales growth and GAAP EPS of about US$0.02. This positive outlook is coupled with the launch of new ultra-low-power PAC1711 and PAC1811 digital power monitors, signaling Microchip's strategic alignment with AI infrastructure and electrification markets. The company's stock rose 6.7% following these announcements, although concerns about high leverage and competition persist.

**5. Microchip Technology Incorporated (NASDAQ:MCHP) Given Consensus Rating of "Moderate Buy" by Brokerages**
- Source: MarketBeat | 20251210T061951 | Somewhat-Bullish | Relevance: 98%
- Microchip Technology (NASDAQ:MCHP) has received a "Moderate Buy" consensus rating from twenty-one analysts, with an average 12-month price target of $74.95. The company recently reported an EPS beat of $0.35 against estimates of $0.33, with revenue of $1.14 billion. Insider transactions show CFO James Eric Bjornholt sold 4,292 shares, reducing his holding by 12.48%.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | B of A Securiti | $72 | $67 | +7% |
| 2025-12-04 | Needham | $75 | $73 | +3% |
| 2025-12-03 | Rosenblatt | $80 | $80 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | B of A Securiti | main | Neutral |
| 2025-12-04 | Needham | main | Buy |
| 2025-12-03 | Rosenblatt | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.27M) |
| Sells | 6 ($9.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.3% (+2.1%)
- Blackrock Inc.: 9.7% (-2.0%)
- Tudor Investment Cor: 9.5% (+100.0%)
- State Street Corpora: 5.2% (-11.9%)
- Boston Partners: 3.0% (+9.5%)

### Key Risks

1. Insider selling cluster: $9.3M in recent transactions.
2. Valuation stretched: PEG 5.7x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 5.70 signals overvaluation risk, limited margin of safety. Forward P/E 27.7x attractive for 72% earnings growth. Balance sheet: strong liquidity (2.2x). Analyst sentiment positive (2 raises, avg +5%). Insider selling cluster ($9.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.3B |
| Beta | 1.46 |
| 52W Range | $34.13 - $77.20 |
| Short Interest | 5.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.70 |
| Forward P/E | 27.7 |
| Current P/E | 47.6 |
| YoY Growth | 71.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 14.9% to 9.4% (-5.5% in 5 days), indicating relative weakness vs NASDAQ. Extended beyond STRENGTH zone (9.4% > 6.0%), caution on chasing. MRS_5 at 2.5% confirms short-term momentum alignment. Outperforming sector by 8.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.00), confirming momentum. RSI overbought at 74, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 9.42% (CS: 97) | Strong |
| RSI_14 | 73.9 | Overbought |
| MACD Histogram | 2.00 | Bullish |
| vs SMA20 | 1.205x | Above |
| vs SMA50 | 1.138x | Above |
| vs SMA200 | 1.143x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $69.09
- **Stop Loss:** $64.31 (6.9% risk)
- **Target:** $73.87 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 288
- **Position Value:** $19,897.92
- **Portfolio %:** 19.90%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +4.9% |
| 2025Q2 | $0.24 | $0.27 | +13.2% |
| 2025Q1 | $0.10 | $0.11 | +5.3% |
| 2024Q4 | $0.28 | $0.20 | -28.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*